首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Grafting of genetically modified cells: effects of acetylcholine release in vivo.
Authors:Dusica Maysinger  Pedro Piccardo  Michel Goiny and A Claudio Cuello
Institution:

1 Department of Pharmacology and Therapeutics, McGill University, McIntyre Medical Sciences Building, 3655 Drummond Street, Montreal, Quebec, Canada H3G 1Y6

2 Department of Pharmacology, Karolinska Institute, Solnavagen 1, Doktorsringen 20, S-104 01, Stockholm, Sweden

Abstract:In this study, microdialysis was used to investigate functional recovery of central cholinergic neurons in the forebrain of rats with cortical devascularizing lesions. Mature male rats were unilaterally lesioned by disruption of the pia arachnoid vessels and genetically modified fibroblasts secreting nerve growth factor (NGF) were placed at the site of the lesion. One month following surgery, microdialysis probes were installed in the remaining cortex and were perfused with artificial cerebrospinal fluid (csf) containing neostigmine (5 nM) and/or KCl (100 mM). The basal (non-stimulated) release of acetylcholine (ACh) in the cortex was similar in all experimental groups, whereas KCl stimulated release of ACh was significantly augmented (P < 0.05) in the ipsilateral remaining cortex in lesioned animals that have been implanted with fibroblasts secreting NGF. These results suggest that NGF secreted by genetically engineered fibroblasts modulates neuroplasticity in the adult mammalian CNS and may favour recovery of cortical function following injury.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号